Latest filing published 09 Feb 2023 for 2seventy bio, Inc., €822.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Nicola Heffron: trading record in brief
Nicola Heffron (chief executive) discloses dealings in 2seventy bio, Inc. to SEC (Form 4). Over a trading history stretching from 11 November 2021 to 7 February 2023, the count stands at 14 filings.
Sales make up the whole of the open-market record (8 sales, €152k). Besides market trades, the filings include 6 share grants. 2023 to date brings no purchases and 3 sales.
The latest filing, published on 9 February 2023, reports an open-market sale of €822 in 2seventy bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nicola Heffron
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 60 shares@ US$14.700.6% of flowCommon StockSEC:0001562180-23-001182:0
- 128 shares@ US$10.62810.9% of flowCommon StockSEC:0001562180-23-000484:0
- 584 shares@ US$10.33474.0% of flowCommon StockSEC:0001562180-23-000358:0
- 272 shares@ US$15.43282.8% of flowCommon StockSEC:0001562180-22-008110:0
- 7,697 shares@ US$13.9773.0% of flowCommon StockSEC:0001562180-22-007877:0
- 42,500 shares0Common StockSEC:0001562180-22-003847:0
- 467 shares@ US$15.41394.9% of flowCommon StockSEC:0001562180-22-001227:0
- 257 shares@ US$31.0615.5% of flowCommon StockSEC:0001885058-21-000003:0
- 2,953 shares0Common StockSEC:0001628280-21-023468:0
9 of 9 declarations
